Collaborative Care in Posttraumatic Epilepsy
Collaborative Care for Anxiety and Depression in Posttraumatic Epilepsy
Collaborative Care for Anxiety and Depression in Posttraumatic Epilepsy
Sponsor study identifier
Secondary identifiers
OTHER · Department of Defense
OTHER · CDMRP
interventional
40
1 country
1
Study Start
April 30, 2023
Actual (reported)Primary Completion
May 19, 2026
Actual (reported)Study Completion
May 19, 2026
Actual (reported)The purpose of this research is to evaluate a 6 month change in quality of life in subjects who receive collaborative care calls compared to those subjects who receive usual neurology care. This is a 2-site trial comparing a 24 week neurology-based collaborative care program to usual neurology care among a total of 60 adults with post-traumatic epilepsy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 19, 2026
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 25, 2022
Actual (reported)April 29, 2022
Actual (reported)April 30, 2023
Actual (reported)May 19, 2026
Actual (reported)May 19, 2026
Actual (reported)Emotional Subscale-Change in Quality of Life in Epilepsy-31(QOLIE-31)
This is a clinically meaningful patient reported outcome measure that was demonstrated to improve in collaborative care efficacy trials in distinct patient groups (including with various different types of medical illness) Score ranges from 0-100 with higher score indicating better quality of life
Baseline through Month 6
Subject Adherence to Intervention
Week 12
Change in Epilepsy specific QOLIE-31 score
Baseline through Month 6
Change in Beck Depression Inventory-II (BDI-II) score
From baseline through Month 6
Change in Beck Anxiety Index (BAI) score
From baseline through Month 6
Feasibility of Intervention Measure (FIM)-Subject Perspective
Baseline and Month 3
FIM-Neurologist Perspective
Baseline and Month 3
Acceptability of Intervention Measure (AIM)-Subject Perspective
Baseline and Month 3
Participants in this arm will receive 24 weeks of neurology based collaborative care.
Participants in this arm will receive provider-recommended clinic visits, prescriptions, testing, and referrals.
Twenty-four week, evidence-based remote collaborative care model initiated around the time of a neurology visit. The collaborative care team roles include the care manager, psychiatrist, and psychologist/social worker who interact with the patient participant and the patient's neurologist.
Usual neurology care means ongoing, epilepsy provider-recommended clinic visits, prescriptions, testing and referrals from their epilepsy provider. Mental health referrals or prescribing of antidepressants may potentially occur in this group; these types of interventions will be tracked at outcome assessments.
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, 27157, United States
Munger Clary HM, Snively BM, Cagle C, Kennerly R, Kimball JN, Alexander HB, Brenes GA, Moore JB, Hurley RA. Collaborative Care to Improve Quality of Life for Anxiety and Depression in Posttraumatic Epilepsy (CoCarePTE): Protocol for a Randomized Hybrid Effectiveness-Implementation Trial. JMIR Res Protoc. 2024 Nov 13;13:e59329. doi: 10.2196/59329.
Heidi M. Munger Clary, MD, MPH
Atrium Health Wake Forest Baptist
40 participants (actual enrollment reported by the registry).
First Submitted
April 25, 2022
First Posted
April 29, 2022
Study Start
April 30, 2023
Actual (reported)Neuroimaging Biomarker for Seizures
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
May 19, 2026
Actual (reported)Study Completion
May 19, 2026
Actual (reported)Last Updated
October 13, 2026
Record last verified: 2026-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: